Diagnostic Study of Patients With Stage I Testicular Cancer

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 16, 1999

Primary Completion Date

December 31, 2004

Conditions
Testicular Germ Cell Tumor
Interventions
OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

radionuclide imaging

Trial Locations (12)

43206

CCOP - Columbus, Columbus

44109

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland

49007

West Michigan Cancer Center, Kalamazoo

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

76508

CCOP - Scott and White Hospital, Temple

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

60611-4494

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

46202-5289

Indiana University Cancer Center, Indianapolis

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

49007-3731

CCOP - Kalamazoo, Kalamazoo

19111-2497

Fox Chase Cancer Center, Philadelphia

53792-0001

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003800 - Diagnostic Study of Patients With Stage I Testicular Cancer | Biotech Hunter | Biotech Hunter